The size of the Middle East and Africa Western blotting market has been estimated at USD 111.89 million in 2023. It is expected to be worth USD 122.37 million by 2028, growing at 1.81% CAGR from 2023 to 2028.
Western blotting has been utilized in the pharmaceutical, biopharmaceutical, and biotechnology industries for disease diagnosis, biomedical and biochemical research, food and beverage, agricultural, and quality control testing. Due to the rising incidence of diseases in the Middle East and Africa, western blot techniques are rapidly increasing.
The Middle East and Africa market for western blotting systems is growing due to the UAE's and Kuwait's strong economic development. Because AIDS is concentrated in a few countries, raising awareness about the implications of unsafe sexual behavior, particularly among high-risk groups, is the most effective strategy for combating the illness. Increased efforts and funding in research and the ever-expanding usage of western blotting in the field of proteomics & development by various pharmaceutical and biotechnology companies are all significant factors driving the growth of the western blotting market.
In the United Arab Emirates, marginalization and social stigma associated with AIDS and people thought to be at high risk of contracting the disease have hampered efforts to prevent HIV. In the Middle East and Africa, lack of public awareness and the high cost of therapy are limiting concerns; people cannot travel from remote locations. In addition, the shortage of qualified professional doctors to treat patients in remote places impedes the growth of the MEA western blotting market.
This research report on the MEA western blotting market has been segmented and sub-segmented into the following categories:
By End User:
Geographically, MEA western blotting market had a moderate share in the global market in 2020. As the incidence of HIV diagnoses among people aged 15 to 29 climbs, the market for western blotting in the UAE is rising. However, Kuwait's traditional lifestyle, combined with the country's dire legal environment, is stifling demand for western technology systems.
Companies like Bio-Rad, Thermo Fisher Scientific, and others are active. Due to the adaptable nature of the population to novel products or technologies, companies can establish their novel product launches in the UAE, which is assisting the market studied to grow in this region.
KEY MARKET PLAYERS:
Countries that are playing a prominent role in the MEA Western blotting market profiled in the report are Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., GE Healthcare, Advansta, Inc., LI-COR Biosciences, PerkinElmer Inc., Bio-Techne Corporation, Merck KGaA, F. Hoffmann-La Roche Ltd., and Cell Signaling Technology.
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: [email protected]